Immunotherapy for Recurrent and Metastatic Cervical Cancer: A Review
Objectives: This review aims to summarize the current literature on recurrent and metastatic (r/m) cervical cancer, especially first-line and second-line immunotherapy. Clinical benefits including efficacy and safety of new therapeutic options are also reviewed. Mechanism: The published relevant art...
Saved in:
| Main Authors: | Yuke Wu, Xiang He |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
IMR Press
2024-07-01
|
| Series: | Clinical and Experimental Obstetrics & Gynecology |
| Subjects: | |
| Online Access: | https://www.imrpress.com/journal/CEOG/51/7/10.31083/j.ceog5107155 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The efficacy of first and second immunotherapy exposure in patients with recurrent or metastatic cervical cancer
by: Mingxiu Ju, et al.
Published: (2024-10-01) -
Immunotherapy in cervical cancer: an innovative approach for better treatment outcomes
by: Treshita Dey, et al.
Published: (2025-03-01) -
A phase 2 study of tislelizumab combined with bevacizumab and chemotherapy as first-line treatment for persistent, recurrent, or metastatic cervical cancerResearch in context
by: Qiang Wen, et al.
Published: (2025-07-01) -
The clinical-immunological analysis of a specific and combined immunotherapy of patients with cervical cancer
by: D. K. Kenbayeva, et al.
Published: (2014-07-01) -
Injecting hope: the potential of intratumoral immunotherapy for locally advanced and metastatic cancer
by: Marketa Skalickova, et al.
Published: (2025-01-01)